Literature DB >> 20021205

miR-31: a master regulator of metastasis?

Thomas D Schmittgen1.   

Abstract

Evaluation of: Valastyan S, Reinhardt F, Benaich N et al.: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137(6), 1032-1046 (2009). Several microRNAs (miRNAs) regulate various steps of the metastatic cascade; however, they typically regulate both metastasis-related genes and genes involved in proliferation, cell-cycle regulation or apoptosis. miR-31 was determined to regulate a number of metastasis-related genes in breast cancer cells and tissues. Using a variety of approaches, it was demonstrated that cellular levels of miR-31 correlated with the cell's ability to invade and metastasize; cells with increased levels of the miRNA were less metastatic. These studies were extended to patient's tissues, demonstrating that breast cancer patients with higher miR-31 expression, or lower expression of the miR-31 target genes, had prolonged survival. A miRNA that works pleiotropically to regulate invasion and metastasis has been identified, suggesting a new pathway for therapeutic intervention of metastasis in breast cancer.

Entities:  

Year:  2010        PMID: 20021205     DOI: 10.2217/fon.09.150

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  12 in total

1.  microRNA-31 modulates skeletal patterning in the sea urchin embryo.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Development       Date:  2015-09-23       Impact factor: 6.868

2.  Is microRNA-31 a key regulator of breast tumorigenesis?

Authors:  Tomasz Powrózek; Teresa Małecka-Massalska
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

3.  miRNA Expression Change in Dorsal Root Ganglia After Peripheral Nerve Injury.

Authors:  Hsueh-Ling Chang; Hung-Chen Wang; Yi-Ta Chunag; Chao-Wen Chou; I-Ling Lin; Chung-Sheng Lai; Lin-Li Chang; Kuang-I Cheng
Journal:  J Mol Neurosci       Date:  2016-12-24       Impact factor: 3.444

4.  Role of MicroRNA-31 (miR-31) in Breast Carcinoma Diagnosis and Prognosis.

Authors:  Amal F Gharib; Amany Salah Khalifa; Emad Mohamed Eed; Hamsa Jameel Banjer; Ashjan Ali Shami; Ahmad El Askary; Wael H Elsawy
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

Review 5.  miRNAs in head and neck cancer revisited.

Authors:  Rahul Nagadia; Pratibala Pandit; William B Coman; Justin Cooper-White; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2013-01-22       Impact factor: 6.730

6.  Identification and pathway analysis of microRNAs with no previous involvement in breast cancer.

Authors:  Sandra Romero-Cordoba; Sergio Rodriguez-Cuevas; Rosa Rebollar-Vega; Valeria Quintanar-Jurado; Antonio Maffuz-Aziz; Gerardo Jimenez-Sanchez; Veronica Bautista-Piña; Rocio Arellano-Llamas; Alfredo Hidalgo-Miranda
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

Review 7.  Therapeutic evaluation of microRNAs by molecular imaging.

Authors:  Thillai V Sekar; Ramkumar Kunga Mohanram; Kira Foygel; Ramasamy Paulmurugan
Journal:  Theranostics       Date:  2013-12-06       Impact factor: 11.556

8.  MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells.

Authors:  Aoxue Wang; Ning Xu Landén; Florian Meisgen; Warangkana Lohcharoenkal; Mona Ståhle; Enikö Sonkoly; Andor Pivarcsi
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

Review 9.  Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT.

Authors:  Eugenio Zoni; Gabri van der Pluijm; Peter C Gray; Marianna Kruithof-de Julio
Journal:  J Oncol       Date:  2015-03-25       Impact factor: 4.375

10.  MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.

Authors:  Fateen Farhana Ibrahim; Rahman Jamal; Saiful Effendi Syafruddin; Nurul Syakima Ab Mutalib; Sazuita Saidin; Reena Rahayu MdZin; Mohammad Manir Hossain Mollah; Norfilza Mohd Mokhtar
Journal:  J Ovarian Res       Date:  2015-08-12       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.